AzTrials
AzTrials

Childhood Obesity PeventionVACOPPNCT00970710

Vaasa Childhood Obesity Primary Prevention Study

A study testing Vaasa Childhood Obesity Primary Prevention Study in people with Childhood Obesity Pevention, run by Tampere University at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to prevent childhood obesity with early life (pregnancy) intensified counselling. The recruited intervention group is pregnant mothers who are at risk to get gestational diabetes. Read more about this study

Who is it for?
Ages Up to 6 yearsHealthy volunteers can take part
Conditions the study is for
Childhood Obesity Pevention
What is being tested?
Vaasa Childhood Obesity Primary Prevention Study
Could I receive a placebo?
No, everyone receives an active treatment
How many people
185 participants
Where
1 siteFinland
Study dates
1 Jan 2009to 31 Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Pregnant women who are at risk to get gestational diabetes.

Who cannot join

  • Foreigner with language problems
  • Major psychosocial problems
  • Diabetes mellitus type I or II
  • Physical disability,
  • Major medical problems in pregnancy

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Health care center in Vaasa

    Vaasa, 65320

Other trials in Finland

About this study

This study aims to prevent childhood obesity with early life (pregnancy) intensified counselling. The recruited intervention group is pregnant mothers who are at risk to get gestational diabetes. Lifestyle intervention (nutritional and physical activity) begins during pregnancy in maternity clinics and continues in child wellfare clinics until the child is 5 years of age.

Being tested
Vaasa Childhood Obesity Primary Prevention Study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vaasa Childhood Obesity Primary Prevention StudyBehavioural

    Also called VACOPP

    Intensified counselling concerning healthy diet and suitable physical activity during pregnancy to mothers in the intervention group continuing in child health care clinic visits with the offspring until child's age of 5 year.

Study groups in NCT00970710
Study groupRoleWhat they receive
Lifestyle counselingExperimentalVACOPP (Vaasa Childhood Obesity Primary Prevention Study): Intensified lifestyle counseling including physical activity and nutritional information beginning during maternity health care and continuing during child health care clinic visits.
Receives: Behavioral: Vaasa Childhood Obesity Primary Prevention Study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preventing childhood obesity

    Difference in offspring weight gain compared to control group

    Measured: Offspring age until six years

Secondary outcomes (2)
  1. lower cholesterol values

    Measured: up to six years

  2. lower HOMA-index

    Measured: up to six years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2009 (estimated)
  2. Study start1 Jan 2009
  3. Primary completion31 Jan 2017
  4. Study completion31 Jan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Pragmatic controlled trial
Masking
None (open label)
Enrolment
185 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00970710
Sponsor's protocol ID
100454
Acronym
VACOPP
Status last verified
Feb 2017
First submitted
1 Sep 2009
Last updated
14 Feb 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Mustila T, Raitanen J, Keskinen P, Luoto R. A pragmatic controlled trial to prevent childhood obesity within a risk group at maternity and child health-care clinics: results up to six years of age (the VACOPP study). BMC Pediatr. 2018 Feb 27;18(1):89. doi: 10.1186/s12887-018-1065-3.

    PubMed 29486763
  • Mustila T, Raitanen J, Keskinen P, Saari A, Luoto R. Pragmatic controlled trial to prevent childhood obesity in maternity and child health care clinics: pregnancy and infant weight outcomes (the VACOPP Study). BMC Pediatr. 2013 May 20;13:80. doi: 10.1186/1471-2431-13-80.

    PubMed 23688259
  • Mustila T, Keskinen P, Luoto R. Behavioral counseling to prevent childhood obesity--study protocol of a pragmatic trial in maternity and child health care. BMC Pediatr. 2012 Jul 3;12:93. doi: 10.1186/1471-2431-12-93.

    PubMed 22759439

Questions about this trial

What is this clinical trial studying?

A study testing Vaasa Childhood Obesity Primary Prevention Study in people with Childhood Obesity Pevention, run by Tampere University at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preventing childhood obesity (time frame: Offspring age until six years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00970710, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in